Key result
Dose-adjusted aspirin may resolve sticky platelet syndrome complications and graft dysfunction in renal transplant recipients.
Why the study?
Sticky platelet syndrome is an underrecognized cause of graft dysfunction and thromboembolic complications in renal transplant recipients, with potential increased risk due to immunosuppressive drugs.
Case Report (n=3)
Sticky platelet syndrome is an underrecognized cause of severe thromboembolic complications and graft dysfunction in renal transplant recipients, highlighting the need for screening and acetylsalicylic acid therapy.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to consider screening in unexplained graft thrombosis; leaves open need for prospective validation of aspirin therapy.
Sticky platelet syndrome (SPS) leads to hyperaggregabilty of platelets in response to physiologic stimuli. In this report we describe three patients with clinical symptoms of SPS after renal transplantation. The first patient developed an infarction of her transplant kidney with additional, subsequent renal microinfarctions. The second patient suffered multiple strokes and deep vein thrombosis with episodes of pulmonary embolism and ischemic bowel disease due to colonic microinfarctions. The third patient experienced a long episode of unexplained respiratory and graft dysfunction immediately after transplantation until therapy for SPS was initiated, at which point symptoms resolved quickly. Kidney transplant recipients with SPS may be at increased risk of developing thrombosis, given that most immunosuppressive drugs are known to induce either endothelial cell damage or augment platelet aggregation. All patients awaiting renal transplantation should be screened for a history of thrombosis and, if appropriate, tested for SPS. Affected patients should receive dose-adjusted acetylsalicylic acid.
No takes yet. Share an insight, caveat, or question.
Mühlfeld et al. (2007) conducted a case report in Sticky platelet syndrome in renal transplant recipients (n=3). Sticky platelet syndrome was evaluated on Thromboembolic complications and graft dysfunction. Sticky platelet syndrome in renal transplant recipients can lead to severe thromboembolic complications and graft dysfunction, which may resolve with dose-adjusted acetylsalicylic acid therapy.
Synapse has enriched 10 related papers. Consider them for comparative context: